Search

Each record is a registered study, a systematic-review registration or a publication. A registered or ongoing study is not a finding, and animal or cell research does not show an effect in people. The same study can appear under more than one subject, so the number of records is not a count of independent studies. You can also search an exact DOI, PubMed ID, NCT or CRD number. How to read these records.

40 study records (showing up to 30 per record type)

• Registered trial NCT04484467 Completed (results not assessed here)
  Efficacy and Safety of a Food Supplement With Standardized Menthol, Limonene, and Gingerol Content in Patients With Irritable Bowel Syndrome
  Condition or outcome area: Irritable Bowel Syndrome|Irritable Bowel Syndrome With Diarrhea|Irritable Bowel Syndrome With Constipation|Irritable Bowel Syndrome Mixed
  2018-02-09 · Subject: Alpha-Limonene; Limonene; d-Terpinolene; (A)limonene; (+)-Dipentene; dl-Limonene; limonen; Goldflush II; p-Mentha-1,8-diene; Dipenten · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT01246804 Phase 1 Completed (results not assessed here)
  The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER)
  Condition or outcome area: HIV Infections|Depression|Mild Cognitive Impairment
  2010-11 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Systematic review registration CRD42023373613 Registered protocol, no results here: Review Completed not published
  Therapeutic Effects and Mechanisms of Action of Ginger and its Bioactive Components on Inflammatory Response, Oxidative Stress, Immune System and Organ Failure in Sepsis
  2023-05-09 · Subject: 6-shogaol; Shogaol; 555-66-8; [6]-Shogaol; enexasogaol; (6)-Shogaol; 23513-13-5; (E)-1-(4-hydroxy-3-methoxyphenyl)dec-4-en-3-one; Trans-6-Shogaol; 1-(4-hydroxy-3-methoxyphenyl)dec-4-en-3-one · open the ingredient record
• Systematic review registration CRD42023403863 Registered protocol, no results here: Review Ongoing
  Pregnancy risks of 30 pregnancy-related Chinese herbs: A systematic review and risk evaluation
  2023-05-09 · Subject: Sheng Jiang; 生姜; Fresh Ginger; Rhizoma Zingiberis Recens; Zingiberis Rhizoma Recens · open the herb record
• Systematic review registration CRD42023403863 Registered protocol, no results here: Review Ongoing
  Pregnancy risks of 30 pregnancy-related Chinese herbs: A systematic review and risk evaluation
  2023-05-09 · Subject: Gan Jiang; 干姜; Dried Ginger; Zingiber; Rhizoma Zingiberis; Zingiberis Rhizoma · open the herb record
• Systematic review registration CRD42023451058 Registered protocol, no results here: Review Ongoing
  Efficacy of Xiaobanxia decoction on chemotherapy-induced nausea and vomiting: A protocol for systematic review and meta-analysis
  Condition or outcome area: Xiaohuansia Decoction is from "The Essentials of the Golden Chamber" by Zhang Zhongjing of the Eastern Han Dynasty. It consists of two flavors: hemixia and ginger. Numerous studies have confirmed the efficacy of Xiaohuansha Decoction in the prevention and treatment of CINV. It has been found that its anti-vomiting mechanism mainly involves the following aspects. First, it regulates the anabolism of 5-HT, SP and DA in the peripheral and central systems and blocks the anabolism of 5-HT, SP and DA.
  2023-08-14 · Subject: Xiao Ban Xia Tang; 小半夏汤; Xiao Ban Xia Decoction · open the formula record
• Systematic review registration CRD42015019039 Registered protocol, no results here: Review Ongoing
  The effects of curcumin on musculoskeletal pain: a systematic review protocol
  Condition or outcome area: Curcuma longa (turmeric) from the Ginger family (Zingiberacea) is native to Southeast India, and has been used for centuries in cooking and in medicine. Turmeric contains at least three naturally-occurring polyphenols termed curcuminoids: curcumin; demethoxycurcumin; and bisdemethoxycurcumin. The three polyphenols found in turmeric are postulated to have various bioactive effects, and there is evidence for their effectiveness in the treatment of joint inflammation, intervertebral disc inflam
  2015-03-31 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42022334940 Registered protocol, no results here: Review Ongoing
  Anticancer effects of gingerol, shogaol and curcumin in cervical cancer: A systemic review.
  2022-06-05 · Subject: Gingerol* · open the ingredient record
• Systematic review registration CRD42022334940 Registered protocol, no results here: Review Ongoing
  Anticancer effects of gingerol, shogaol and curcumin in cervical cancer: A systemic review.
  2022-06-05 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Systematic review registration CRD42022334940 Registered protocol, no results here: Review Ongoing
  Anticancer effects of gingerol, shogaol and curcumin in cervical cancer: A systemic review.
  2022-06-05 · Subject: 6-shogaol; Shogaol; 555-66-8; [6]-Shogaol; enexasogaol; (6)-Shogaol; 23513-13-5; (E)-1-(4-hydroxy-3-methoxyphenyl)dec-4-en-3-one; Trans-6-Shogaol; 1-(4-hydroxy-3-methoxyphenyl)dec-4-en-3-one · open the ingredient record
• Systematic review registration CRD42022334940 Registered protocol, no results here: Review Ongoing
  Anticancer effects of gingerol, shogaol and curcumin in cervical cancer: A systemic review.
  2022-06-05 · Subject: 6-gingerol; Gingerol; gingerol; 23513-14-6; [6]-Gingerol; (6)-Gingerol; (S)-(+)-[6]Gingerol; (S)-(6)-Gingerol; (S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one; (5S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one · open the ingredient record
• Systematic review registration CRD42020166300 Registered protocol, no results here: Review Ongoing
  “Comparative Efficiency Of Ginger Extract Gel With And Without Curcumin Gel For Management Of Homogeneous Leukoplakia Evaluated By Salivary Malondialdehyde Level” (Biomarker)
  Condition or outcome area: Oral leukoplakia (OL) is the most frequent precancerous lesion of the oral cavity. Oral leukoplakia is defined by WHO (1997) as “a predominantly white lesion of the oral mucosa that cannot be characterised as any otherdefinable lesion” In 2012 van der Waal proposed a new definition which seems more opportune as it includes the histological confirmation: “A predominantly white lesion or plaque of questionable behaviour having excluded, clinically and histopathologically, any other definable white
  2020-04-28 · Subject: Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Kacha haldi; Indian saffron; Curcuma; Gelbwurz; Haldar; Curcumin I · open the ingredient record
• Publication PMID 33725040 Research model: Animal & Cell Experiment
  The protective role of Zingerone in a murine asthma model via activation of the AMPK/Nrf2/HO-1 pathway
  Condition or outcome area: attenuated airway hyperresponsiveness; chronic airway inflammation; Asthma; asthma; goblet cell hyperplasia
  Food Funct · 2021 · Subject: Zingerone; Vanillylacetone; 122-48-5; 4-(4-Hydroxy-3-methoxyphenyl)butan-2-one; Zingherone; Zingiberone; 4-(4-Hydroxy-3-methoxyphenyl)-2-butanone; Gingerone; Vanillyl acetone; 2-Butanone, 4-(4-hydroxy-3-methoxyphenyl)- · open the ingredient record · DOI 10.1039/d0fo01583k
• Publication PMID 32898532 Research model: Animal Experiment
  Zingerone attenuates vancomycin-induced hepatotoxicity in rats through regulation of oxidative stress, inflammation and apoptosis
  Condition or outcome area: hepatotoxicity; methicillin-resistant Staphylococcus aureus; nephrotoxicity
  Life Sci · 2020 · Subject: Zingerone; Vanillylacetone; 122-48-5; 4-(4-Hydroxy-3-methoxyphenyl)butan-2-one; Zingherone; Zingiberone; 4-(4-Hydroxy-3-methoxyphenyl)-2-butanone; Gingerone; Vanillyl acetone; 2-Butanone, 4-(4-hydroxy-3-methoxyphenyl)- · open the ingredient record · DOI 10.1016/j.lfs.2020.118382
• Publication PMID 34046952 Research model: Cell Experiment
  Zerumbone, a ginger sesquiterpene, inhibits migration, invasion, and metastatic behavior of human malignant glioblastoma multiforme in vitro
  Condition or outcome area: malignant tumor; glioblastoma multiforme
  Biofactors · 2021 · Subject: Zerumbone; 471-05-6; (2E,6E,10E)-2,6,9,9-tetramethylcycloundeca-2,6,10-trien-1-one; (E,E,E)-2,6,9,9-Tetramethyl-2,6,10-cycloundecatrien-1-one; 2E,6E,9E-humulatrien-8-one; CHEBI:63892; CHEMBL245412; Zerumbone (6CI,7CI); erumbone; MFCD03700769 · open the ingredient record · DOI 10.1002/biof.1756
• Publication PMID 34376189 Research model: Cell Experiment
  [6]-Paradol suppresses proliferation and metastases of pancreatic cancer by decreasing EGFR and inactivating PI3K/AKT signaling
  Condition or outcome area: pancreatic cancer
  Cancer Cell Int · 2021 · Subject: Paradol; 27113-22-0; 6-Paradol; [6]-Paradol; 1-(4-hydroxy-3-methoxyphenyl)decan-3-one; 5-Paradol; 3-Decanone, 1-(4-hydroxy-3-methoxyphenyl)-; [6]-Gingerone; 1-(4-Hydroxy-3-methoxyphenyl)-3-decanone; CHEBI:10137 · open the ingredient record · DOI 10.1186/s12935-021-02118-0
• Publication PMID 33094793 Research model: Animal Experiment
  6-Paradol and its glucoside improve memory disorder in mice
  Food Funct · 2020 · Subject: Paradol; 27113-22-0; 6-Paradol; [6]-Paradol; 1-(4-hydroxy-3-methoxyphenyl)decan-3-one; 5-Paradol; 3-Decanone, 1-(4-hydroxy-3-methoxyphenyl)-; [6]-Gingerone; 1-(4-Hydroxy-3-methoxyphenyl)-3-decanone; CHEBI:10137 · open the ingredient record · DOI 10.1039/d0fo01975e
• Publication PMID 35326237 Research model: Cell Experiment
  Gingerenone A Induces Antiproliferation and Senescence of Breast Cancer Cells
  Condition or outcome area: anti-breast-cancer; breast cancer; Gingerenone
  Antioxidants (Basel) · 2022 · Subject: Gingerenone a; Gingerenone A; 128700-97-0; (E)-1,7-bis(4-hydroxy-3-methoxyphenyl)hept-4-en-3-one; 1,7-bis(4-hydroxy-3-methoxyphenyl)hept-4-en-3-one; AS-HK014; CHEBI:5352; 4-Hepten-3-one, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (4E)-; (4E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-4-hepten-3-one; (E)-Gingerenone A · open the ingredient record · DOI 10.3390/antiox11030587
• Publication PMID 34393792 Research model: Animal Experiment
  8-Gingerol Ameliorates Myocardial Fibrosis by Attenuating Reactive Oxygen Species, Apoptosis, and Autophagy via the PI3K/Akt/mTOR Signaling Pathway
  Condition or outcome area: myocardial fibrosis
  Front Pharmacol · 2021 · Subject: (8)-gingerol; (8)-Gingerol; 8-Gingerol; 23513-08-8; [8]-Gingerol; (5s)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)dodecan-3-one; (S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-dodecanone; UNII-LB0IJB138K; LB0IJB138K; (S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)dodecan-3-one · open the ingredient record · DOI 10.3389/fphar.2021.711701
• Publication PMID 35281937 Research model: Cell Experiment
  Ginger Constituent 6-Shogaol Inhibits Inflammation- and Angiogenesis-Related Cell Functions in Primary Human Endothelial Cells
  Condition or outcome area: nausea; diarrhea; rheumatoid arthritis
  Front Pharmacol · 2022 · Subject: 6-shogaol; Shogaol; 555-66-8; [6]-Shogaol; enexasogaol; (6)-Shogaol; 23513-13-5; (E)-1-(4-hydroxy-3-methoxyphenyl)dec-4-en-3-one; Trans-6-Shogaol; 1-(4-hydroxy-3-methoxyphenyl)dec-4-en-3-one · open the ingredient record · DOI 10.3389/fphar.2022.844767
• Publication PMID 33416981 Research model: Cell Experiment
  6-Shogaol from ginger shows anti-tumor effect in cervical carcinoma via PI3K/Akt/mTOR pathway
  Condition or outcome area: tumor; cancer; cervical cancer
  Eur J Nutr · 2021 · Subject: 6-shogaol; Shogaol; 555-66-8; [6]-Shogaol; enexasogaol; (6)-Shogaol; 23513-13-5; (E)-1-(4-hydroxy-3-methoxyphenyl)dec-4-en-3-one; Trans-6-Shogaol; 1-(4-hydroxy-3-methoxyphenyl)dec-4-en-3-one · open the ingredient record · DOI 10.1007/s00394-020-02440-9
• Publication PMID 31800263 Research model: Animal & Cell Experiment
  Ginger and its bioactive component 6-shogaol mitigate lung inflammation in a murine asthma model
  Condition or outcome area: Asthma; airway inflammation; asthma
  Am J Physiol Lung Cell Mol Physiol · 2020 · Subject: 6-shogaol; Shogaol; 555-66-8; [6]-Shogaol; enexasogaol; (6)-Shogaol; 23513-13-5; (E)-1-(4-hydroxy-3-methoxyphenyl)dec-4-en-3-one; Trans-6-Shogaol; 1-(4-hydroxy-3-methoxyphenyl)dec-4-en-3-one · open the ingredient record · DOI 10.1152/ajplung.00249.2019
• Publication PMID 31675438 Research model: Animal & Cell Experiment
  6-Shogaol, an active ingredient of ginger, inhibits osteoclastogenesis and alveolar bone resorption in ligature-induced periodontitis in mice
  Condition or outcome area: inflammatory disease; Periodontitis; periodontitis
  J Periodontol · 2020 · Subject: 6-shogaol; Shogaol; 555-66-8; [6]-Shogaol; enexasogaol; (6)-Shogaol; 23513-13-5; (E)-1-(4-hydroxy-3-methoxyphenyl)dec-4-en-3-one; Trans-6-Shogaol; 1-(4-hydroxy-3-methoxyphenyl)dec-4-en-3-one · open the ingredient record · DOI 10.1002/JPER.19-0228
• Publication PMID 36624878 Research model: Animal & Cell Experiment
  6-Gingerol Alleviates Ferroptosis and Inflammation of Diabetic Cardiomyopathy via the Nrf2/HO-1 Pathway
  Condition or outcome area: cardiomyocyte injury; interstitial fibrosis; Diabetes mellitus; cardiomyocyte hypertrophy; diabetic cardiomyopathy
  Oxid Med Cell Longev · 2023 · Subject: 6-gingerol; Gingerol; gingerol; 23513-14-6; [6]-Gingerol; (6)-Gingerol; (S)-(+)-[6]Gingerol; (S)-(6)-Gingerol; (S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one; (5S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one · open the ingredient record · DOI 10.1155/2022/3027514
• Publication PMID 36091803 Research model: Animal Experiment
  6-Gingerol attenuates subarachnoid hemorrhage-induced early brain injury via GBP2/PI3K/AKT pathway in the rat model
  Condition or outcome area: brain injury; subarachnoid hemorrhage; brain edema
  Front Pharmacol · 2022 · Subject: 6-gingerol; Gingerol; gingerol; 23513-14-6; [6]-Gingerol; (6)-Gingerol; (S)-(+)-[6]Gingerol; (S)-(6)-Gingerol; (S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one; (5S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one · open the ingredient record · DOI 10.3389/fphar.2022.882121
• Publication PMID 35728306 Research model: Animal Experiment
  Protective effects and possible mechanism of 6-gingerol against arsenic trioxide-induced nephrotoxicity based on network pharmacological analysis and experimental validation
  Int Immunopharmacol · 2022 · Subject: 6-gingerol; Gingerol; gingerol; 23513-14-6; [6]-Gingerol; (6)-Gingerol; (S)-(+)-[6]Gingerol; (S)-(6)-Gingerol; (S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one; (5S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one · open the ingredient record · DOI 10.1016/j.intimp.2022.108926
• Publication PMID 35245652 Research model: Cell Experiment
  6-Gingerol exerts a protective effect against hypoxic injury through the p38/Nrf2/HO-1 and p38/NF-κB pathway in H9c2 cells
  Condition or outcome area: Cardiomyocyte injury; hypoxia-related oxidative stress
  J Nutr Biochem · 2022 · Subject: 6-gingerol; Gingerol; gingerol; 23513-14-6; [6]-Gingerol; (6)-Gingerol; (S)-(+)-[6]Gingerol; (S)-(6)-Gingerol; (S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one; (5S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one · open the ingredient record · DOI 10.1016/j.jnutbio.2022.108975
• Publication PMID 35003518 Research model: Animal Experiment
  Pretreatment with 6-Gingerol Ameliorates Sepsis-Induced Immune Dysfunction by Regulating the Cytokine Balance and Reducing Lymphocyte Apoptosis
  Condition or outcome area: immunoparalysis; sepsis; Sepsis; polymicrobial sepsis; nosocomial infections; sepsis-induced immune dysfunction; septic insult; multiorgan system failure
  Oxid Med Cell Longev · 2021 · Subject: 6-gingerol; Gingerol; gingerol; 23513-14-6; [6]-Gingerol; (6)-Gingerol; (S)-(+)-[6]Gingerol; (S)-(6)-Gingerol; (S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one; (5S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one · open the ingredient record · DOI 10.1155/2021/5427153
• Publication PMID 34804985 Research model: Cell Experiment
  Pivotal Role of Iron Homeostasis in the Induction of Mitochondrial Apoptosis by 6-Gingerol Through PTEN Regulated PD-L1 Expression in Embryonic Cancer Cells
  Condition or outcome area: Embryonic cancer; cancer
  Front Oncol · 2021 · Subject: 6-gingerol; Gingerol; gingerol; 23513-14-6; [6]-Gingerol; (6)-Gingerol; (S)-(+)-[6]Gingerol; (S)-(6)-Gingerol; (S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one; (5S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one · open the ingredient record · DOI 10.3389/fonc.2021.781720
• Publication PMID 33925065 Research model: Cell Experiment
  Potential Antitumor Effects of 6-Gingerol in p53-Dependent Mitochondrial Apoptosis and Inhibition of Tumor Sphere Formation in Breast Cancer Cells
  Condition or outcome area: ataxia-telangiectasia; tumor; hormone-dependent breast cancer; breast cancer
  Int J Mol Sci · 2021 · Subject: 6-gingerol; Gingerol; gingerol; 23513-14-6; [6]-Gingerol; (6)-Gingerol; (S)-(+)-[6]Gingerol; (S)-(6)-Gingerol; (S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one; (5S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one · open the ingredient record · DOI 10.3390/ijms22094660
• Publication PMID 33670981 Research model: Animal Experiment
  6-Gingerol, a Bioactive Compound of Ginger Attenuates Renal Damage in Streptozotocin-Induced Diabetic Rats by Regulating the Oxidative Stress and Inflammation
  Condition or outcome area: degeneration of pancreatic Langerhans; renal injury; diabetic; hyperlipidaemia; diabetes mellitus; diabetes
  Pharmaceutics · 2021 · Subject: 6-gingerol; Gingerol; gingerol; 23513-14-6; [6]-Gingerol; (6)-Gingerol; (S)-(+)-[6]Gingerol; (S)-(6)-Gingerol; (S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one; (5S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one · open the ingredient record · DOI 10.3390/pharmaceutics13030317
• Publication PMID 33462378 Research model: Animal Experiment
  6-Gingerol protects against cardiac remodeling by inhibiting the p38 mitogen-activated protein kinase pathway
  Condition or outcome area: cardiac hypertrophy; inflammation; transverse aortic constriction; cardiac remodeling; fibrosis
  Acta Pharmacol Sin · 2021 · Subject: 6-gingerol; Gingerol; gingerol; 23513-14-6; [6]-Gingerol; (6)-Gingerol; (S)-(+)-[6]Gingerol; (S)-(6)-Gingerol; (S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one; (5S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one · open the ingredient record · DOI 10.1038/s41401-020-00587-z
• Publication PMID 33281606 Research model: Animal Experiment
  The Inhibitory Effect of 6-Gingerol on Ubiquitin-Specific Peptidase 14 Enhances Autophagy-Dependent Ferroptosis and Anti-Tumor in vivo and in vitro
  Condition or outcome area: Lung cancer; lung cancer; malignant tumor; tumor; tumors
  Front Pharmacol · 2020 · Subject: 6-gingerol; Gingerol; gingerol; 23513-14-6; [6]-Gingerol; (6)-Gingerol; (S)-(+)-[6]Gingerol; (S)-(6)-Gingerol; (S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one; (5S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one · open the ingredient record · DOI 10.3389/fphar.2020.598555
• Publication PMID 32720790 Research model: Cell Experiment
  6-Gingerol protects cardiomyocytes against hypoxia-induced injury by regulating the KCNQ1OT1/miR-340-5p/PI3K/AKT pathway
  Condition or outcome area: heart disease
  Panminerva Med · 2021 · Subject: 6-gingerol; Gingerol; gingerol; 23513-14-6; [6]-Gingerol; (6)-Gingerol; (S)-(+)-[6]Gingerol; (S)-(6)-Gingerol; (S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one; (5S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one · open the ingredient record · DOI 10.23736/S0031-0808.20.03956-7
• Publication PMID 32512025 Research model: Animal Experiment
  6-Gingerol delays tumorigenesis in benzo[a]pyrene and dextran sulphate sodium-induced colorectal cancer in mice
  Condition or outcome area: Colorectal cancer
  Food Chem Toxicol · 2020 · Subject: 6-gingerol; Gingerol; gingerol; 23513-14-6; [6]-Gingerol; (6)-Gingerol; (S)-(+)-[6]Gingerol; (S)-(6)-Gingerol; (S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one; (5S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one · open the ingredient record · DOI 10.1016/j.fct.2020.111483
• Publication PMID 33748100 Research model: Animal & Cell Experiment
  10-Gingerol Suppresses Osteoclastogenesis in RAW264.7 Cells and Zebrafish Osteoporotic Scales
  Condition or outcome area: Osteoporosis; osteoporosis; -associated bone disease
  Front Cell Dev Biol · 2021 · Subject: 10-gingerol; (10)-Gingerol; 23513-15-7; [10]-Gingerol; (S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-tetradecanone; UNII-ND6ZLI4J0V; ND6ZLI4J0V; (5s)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)tetradecan-3-one; (S)- 5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-tetradecanone; MFCD01682694 · open the ingredient record · DOI 10.3389/fcell.2021.588093
• Publication PMID 35335934 Research model: Animal Experiment
  Exploring the Potential Effects and Mechanisms of Asarum sieboldii Radix Essential Oil for Treatment of Asthma
  Condition or outcome area: chronic pulmonary disorder; Asthma; airway remodeling; asthma; obstruction
  Pharmaceutics · 2022 · Subject: Han Cheng Xi Xin; 汉城细辛; Seoul Siebold Wildginger; Asarum Sieboldii · open the herb record · DOI 10.3390/pharmaceutics14030558
• Publication PMID 36195301 Research model: Animal Experiment
  A network pharmacology integrated pharmacokinetics strategy to investigate the pharmacological mechanism of absorbed components from crude and processed Zingiberis Rhizoma on deficiency-cold and hemorrhagic syndrome
  Condition or outcome area: deficiency-cold and hemorrhagic syndrome
  J Ethnopharmacol · 2022 · Subject: Gan Jiang; 干姜; Dried Ginger; Zingiber; Rhizoma Zingiberis; Zingiberis Rhizoma · open the herb record · DOI 10.1016/j.jep.2022.115754
• Publication PMID 22704648 Research model: Animal Experiment
  Effects of the tropical ginger compound,1'-acetoxychavicol acetate, against tumor promotion in K5.Stat3C transgenic mice
  J Exp Clin Cancer Res · 2012 · Subject: 1'-acetoxychavicol acetate; 1'-Acetoxychavicol acetate; 52946-22-2; [4-[(1S)-1-acetyloxyprop-2-enyl]phenyl] acetate; 1'-Acetoxychavicol; (1S)-1-[4-(acetyloxy)phenyl]prop-2-en-1-yl acetate; CHEBI:469; 1'S-1'-Acetoxychavicol acetate; SQV3080A20; (alphaS)-4-(Acetyloxy)-alpha-ethenylbenzenemethanol · open the ingredient record · DOI 10.1186/1756-9966-31-57
• Publication PMID 30449315 Research model: Animal Experiment
  Plant-Derived Exosomal MicroRNAs Shape the Gut Microbiota
  Cell Host Microbe · 2018 · Subject: Sheng Jiang; 生姜; Fresh Ginger; Rhizoma Zingiberis Recens; Zingiberis Rhizoma Recens · open the herb record · DOI 10.1016/j.chom.2018.10.001